2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
63
Breast Neoplasms
28
Neoplasms
5
Neoplasm Metastasis
3
Leiomyoma
3
Cardiovascular Diseases
3
Polycystic Ovary Syndrome
2
Neoplasms by Site
2
Endometrial Neoplasms
2
Breast Diseases
2
Advanced Breast Cancer
2
Stage II Prostate Adenocarcinoma
1
Sleep Wake Disorders
1
Skin Diseases
1
Sexual Dysfunctions, Psychological
1
Sarcopenia
1
Salivary Gland Neoplasms
1
Salivary Gland Adenoma, Pleomorphic
1
Prostatic Neoplasms, Castration-Resistant
1
Prostatectomy
1
Prostate Cancer With ≤10 Bone Metastases
1
Prostate Cancer Metastatic Disease
1
Prostate Cancer Metastatic
1
Pelvic Pain
1
Ovarian Neoplasms
1
Osteoporosis
1
Oligometastatic Prostate Carcinoma
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Metastatic Neuroendocrine Prostate Cancer
1
Interventions
Therapeutics
4
Yoga
2
Tamoxifen
2
Surveys and Questionnaires
2
Psychiatric Rehabilitation
2
Methylphenidate
2
Melatonin
2
Educational Status
2
Early Intervention, Educational
2
Counseling
2
Cognitive Behavioral Therapy
2
Behavior Therapy
2
exemestane
1
Zolpidem
1
Venlafaxine Hydrochloride
1
Valeriana extract
1
Uncertainty
1
Ultraviolet Therapy
1
Triptorelin Pamoate
1
Saline Solution
1
Psychosocial Intervention
1
Phototherapy
1
N-((1-((5-(4-fluorophenyl)-2-methyl-4-thiazolyl)carbonyl)-2-piperidinyl)methyl)-4-benzofurancarboxamide
1
Modafinil
1
Methods
1
Methadone
1
Metformin
1
Hypnosis
1
Gonadotropin-Releasing Hormone
1
Exercise Test
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sleep Wake Disorders
×
Gonadotropin-Releasing Hormone
×
Clear all
NCT00659373
2016-07-25
Co-SOFT
ETOP IBCSG Partners Foundation
Phase 3
Completed
86 enrolled
4 charts